← Eichor
Study identifier: NCT05206682 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of the Therapeutic Effects of Vaginal Repair With Leuprorelin and Vaginal Repair in the Treatment of Cesarean Section Scar Defect

Condition: Cesarean Section; Dehiscence  ·  Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

PhaseNA
Planned participants94
Who can joinFemale, 18 Years to 50 Years
Healthy volunteersNo

About this study

GnRH-a will be used to postpone period after vaginal repair for Cesarean Section Scar Defect(CSD) patients with adenomyosis which will be compared with CSD patients with adenomyosis who receive transvaginal surgery without GnRH-a, whether delayed period improving the CSD prognosis will be assessed.

This description comes directly from the study's public registry record.

Talk to the study team

Wang Xipeng  ·  +862125078999  ·  steveoizzie@icloud.com

Always discuss trial participation with your own doctor first.

Locations (1)

Shanghai Jiaotong University xinhua hospitalShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05206682